Wupeng Liao

1.7k total citations
39 papers, 1.2k citations indexed

About

Wupeng Liao is a scholar working on Molecular Biology, Immunology and Physiology. According to data from OpenAlex, Wupeng Liao has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Immunology and 12 papers in Physiology. Recurrent topics in Wupeng Liao's work include Asthma and respiratory diseases (10 papers), Andrographolide Research and Applications (6 papers) and Antimicrobial Peptides and Activities (6 papers). Wupeng Liao is often cited by papers focused on Asthma and respiratory diseases (10 papers), Andrographolide Research and Applications (6 papers) and Antimicrobial Peptides and Activities (6 papers). Wupeng Liao collaborates with scholars based in Singapore, United States and United Kingdom. Wupeng Liao's co-authors include W.S. Fred Wong, W.S. Daniel Tan, Hong Yong Peh, Shuo Zhou, Dan Mei, Zhang Bao, Tom K. Hei, Simon K. Cheng, Tze Khee Chan and Ruowen Ge and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Wupeng Liao

37 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wupeng Liao Singapore 20 461 223 199 194 138 39 1.2k
W.S. Daniel Tan Singapore 19 497 1.1× 253 1.1× 198 1.0× 236 1.2× 188 1.4× 27 1.4k
In‐Chul Lee South Korea 21 465 1.0× 168 0.8× 173 0.9× 145 0.7× 91 0.7× 81 1.3k
Damodar Gupta India 17 608 1.3× 210 0.9× 294 1.5× 183 0.9× 91 0.7× 34 1.7k
Yuhang Li China 20 552 1.2× 197 0.9× 181 0.9× 281 1.4× 121 0.9× 119 1.4k
Chun-Ling Liang China 21 530 1.1× 148 0.7× 410 2.1× 147 0.8× 99 0.7× 43 1.6k
Shenghao Tu China 20 514 1.1× 168 0.8× 270 1.4× 177 0.9× 98 0.7× 70 1.7k
Youwei Chen China 25 624 1.4× 235 1.1× 264 1.3× 119 0.6× 70 0.5× 91 1.8k
Salman Ahmed Pakistan 18 599 1.3× 290 1.3× 81 0.4× 108 0.6× 53 0.4× 116 1.6k
Roberta Giordo Italy 25 697 1.5× 295 1.3× 110 0.6× 48 0.2× 110 0.8× 56 1.8k
Yuling Liu China 21 447 1.0× 85 0.4× 128 0.6× 100 0.5× 94 0.7× 95 1.6k

Countries citing papers authored by Wupeng Liao

Since Specialization
Citations

This map shows the geographic impact of Wupeng Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wupeng Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wupeng Liao more than expected).

Fields of papers citing papers by Wupeng Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wupeng Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wupeng Liao. The network helps show where Wupeng Liao may publish in the future.

Co-authorship network of co-authors of Wupeng Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Wupeng Liao. A scholar is included among the top collaborators of Wupeng Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wupeng Liao. Wupeng Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liao, Wupeng, et al.. (2025). Calcaratarin D, a labdane diterpenoid, attenuates bleomycin-induced pulmonary fibrosis by blocking Wnt/β-catenin signaling pathway. Pharmacological Research. 216. 107756–107756. 1 indexed citations
3.
Sévoz‐Couche, Caroline, Wupeng Liao, Isabelle Bonne, et al.. (2024). Direct vagus nerve stimulation: A new tool to control allergic airway inflammation through α7 nicotinic acetylcholine receptor. British Journal of Pharmacology. 181(13). 1916–1934. 6 indexed citations
4.
Liao, Wupeng, et al.. (2023). Dexamethasone protects against Aspergillus fumigatus-induced severe asthma via modulating pulmonary immunometabolism. Pharmacological Research. 196. 106929–106929. 10 indexed citations
5.
Liao, Wupeng, et al.. (2023). Targeting the renin angiotensin system for respiratory diseases. Advances in pharmacology. 98. 111–144. 1 indexed citations
6.
Liao, Wupeng, et al.. (2023). Degradation of MK2 with natural compound andrographolide: A new modality for anti-inflammatory therapy. Pharmacological Research. 194. 106861–106861. 8 indexed citations
7.
Liao, Wupeng, et al.. (2022). Calcaratarin D, a labdane diterpenoid, attenuates mouse asthma via modulating alveolar macrophage function. British Journal of Pharmacology. 180(8). 1056–1071. 6 indexed citations
9.
Mei, Dan, et al.. (2020). Activation of angiotensin II type-2 receptor protects against cigarette smoke-induced COPD. Pharmacological Research. 161. 105223–105223. 15 indexed citations
10.
Liao, Wupeng, et al.. (2018). Ribosomal Protein S3 Gene Silencing Protects Against Cigarette Smoke-Induced Acute Lung Injury. Molecular Therapy — Nucleic Acids. 12. 370–380. 19 indexed citations
11.
Tan, W.S. Daniel, et al.. (2018). Andrographolide simultaneously augments Nrf2 antioxidant defense and facilitates autophagic flux blockade in cigarette smoke-exposed human bronchial epithelial cells. Toxicology and Applied Pharmacology. 360. 120–130. 47 indexed citations
12.
Tan, W.S. Daniel, Wupeng Liao, Shuo Zhou, & W.S. Fred Wong. (2017). Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of action. Biochemical Pharmacology. 139. 71–81. 135 indexed citations
13.
Tan, W.S. Daniel, Wupeng Liao, Shuo Zhou, Dan Mei, & W.S. Fred Wong. (2017). Targeting the renin–angiotensin system as novel therapeutic strategy for pulmonary diseases. Current Opinion in Pharmacology. 40. 9–17. 140 indexed citations
14.
Chen, Mo, et al.. (2015). Isthmin is a novel vascular permeability inducer that functions through cell-surface GRP78-mediated Src activation. Cardiovascular Research. 107(1). 131–142. 25 indexed citations
15.
Ng, David S.W., et al.. (2014). Anti-malarial drug artesunate protects against cigarette smoke-induced lung injury in mice. Phytomedicine. 21(12). 1638–1644. 42 indexed citations
16.
Wen, Gengyun, Mike Partridge, Bingyan Li, et al.. (2011). TGFBI expression reduces in vitro and in vivo metastatic potential of lung and breast tumor cells. Cancer Letters. 308(1). 23–32. 60 indexed citations
17.
Liao, Wupeng, Fera Y. Goh, Richard J. Betts, et al.. (2010). A novel anti‐apoptotic role for apolipoprotein L2 in IFN‐γ‐induced cytotoxicity in human bronchial epithelial cells. Journal of Cellular Physiology. 226(2). 397–406. 23 indexed citations
18.
Liao, Wupeng, Zhang Bao, Cheng Chang, Yu‐Keung Mok, & W.S. Fred Wong. (2008). Dendritic cell‐derived interferon‐γ‐induced protein mediates tumor necrosis factor‐α stimulation of human lung fibroblasts. PROTEOMICS. 8(13). 2640–2650. 35 indexed citations
19.
Chan, Jasmine H.P., Wupeng Liao, H. Y. A. Lau, & W.S. Fred Wong. (2007). Gab2 antisense oligonucleotide blocks rat basophilic leukemic cell functions. International Immunopharmacology. 7(7). 937–944. 11 indexed citations
20.
Wong, W.S. Fred, et al.. (2007). Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in a mouse asthma model. European Journal of Pharmacology. 575(1-3). 134–141. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026